Skip to main content

Pyridostigmine (Mestinon)

A cholinesterase inhibitor used to improve muscle strength in myasthenia gravis.

Drug Class: Cholinesterase Inhibitors

4 min read

Pyridostigmine (brand name Mestinon) is a medication that improves communication between nerves and muscles. It's the primary symptomatic treatment for myasthenia gravis, helping to improve muscle strength including the muscles controlling the eyelids and eye movements.

Key Takeaways

  • Improves nerve-muscle communication
  • First-line symptom treatment for myasthenia gravis
  • Works within hours-but effects wear off
  • Doesn't treat underlying disease-just symptoms
  • Dosing must be carefully balanced

How It Works

In myasthenia gravis, antibodies attack the neuromuscular junction, reducing the effect of acetylcholine. Pyridostigmine inhibits acetylcholinesterase, the enzyme that breaks down acetylcholine. This increases acetylcholine levels and improves muscle contraction.

Common Uses

  • Myasthenia gravis-symptomatic treatment
  • Improves ptosis and double vision
  • Helps with weakness and fatigue

Dosing

  • Usually starts at 60mg three times daily
  • Effects begin within 30-60 minutes
  • Last about 3-4 hours
  • Extended-release (Mestinon Timespan) available for overnight
  • Dose adjusted based on symptoms

Side Effects

Common (Cholinergic Effects)

  • Abdominal cramps
  • Diarrhea
  • Increased salivation
  • Sweating
  • Nausea
  • More tearing or nasal secretions
  • Muscle twitching or cramps

Signs of Over-Dosing (Cholinergic Crisis)

Tips for Taking Pyridostigmine

  • Take 30-60 minutes before meals or activities
  • Time doses to cover your weakest periods
  • Take with food if stomach upset occurs
  • Carry medication with you
  • Space doses to avoid peaks and troughs

Important Considerations

  • Symptomatic treatment only-doesn't modify disease
  • Usually combined with immunosuppressive therapy
  • Effects vary throughout the day
  • Dose requirements may change over time
  • Use extra caution if you have asthma, significant heart rhythm disease, or a history of bowel or urinary obstruction; your prescriber needs to know

Pregnancy and Breastfeeding

Tell your neurologist, obstetrician, and anesthesiology team if you are pregnant or breastfeeding. Oral pyridostigmine is commonly used as first-line symptomatic treatment during myasthenia gravis pregnancy, but dose needs can change and over-dosing can worsen secretions, cramps, diarrhea, or weakness. Intravenous anticholinesterase medicines are handled differently in pregnancy and labor because they can trigger uterine contractions. During breastfeeding, LactMed reports low milk levels and does not expect adverse effects in most breastfed infants, but the pediatrician should know about exposure and watch for poor feeding, diarrhea, unusual secretions, or weakness.

Frequently Asked Questions

How quickly will it work?

Effects typically begin within 30-60 minutes and last 3-4 hours. You should notice improvement in ptosis and strength.

Why do I still have symptoms?

Pyridostigmine improves but may not eliminate symptoms. Most myasthenia patients need additional immunosuppressive therapy to control the underlying disease.

What if I miss a dose?

Take it as soon as you remember, then resume your regular schedule. Don't double up on doses.

Can I adjust my own dose?

Work with your doctor on dosing. Taking too much can actually worsen weakness (cholinergic crisis), so increases should be done carefully.

Does pyridostigmine treat the autoimmune attack?

No. It improves signal transmission at the neuromuscular junction. It does not remove the antibodies or prevent future immune activity, which is why many patients also need immune-directed treatment.

Was this article helpful?